To investigate whether roflumilast potentiates the anti-tumor effect of IFN-α in vivo, we used a tumor xenograft model by injecting human 5637 bladder cancer cells into BALB/c nude mice (see materials and methods). Here, IFNA1 is linked to urinary bladder cancer.